Scribe Therapeutics is based in Alameda, California, while Leerink Partners maintains an office in Boston, MA. The article also notes Goldman Sachs has an office in New York.
1 report, 1 independent
Updated Jul 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Scribe Therapeutics is based in Alameda, California, while Leerink Partners maintains an office in Boston, MA. The article also notes Goldman Sachs has an office in New York.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Scribe Therapeutics
genetic medicine therapeutics company from Alameda, California
Nothing else this week.
-
Leerink partners
U.S. investment bank
-
Boston
capital and largest city of Massachusetts, United States
-
New York
state of the United States of America
Related events
- Scribe Therapeutics completed its IPO, led by Leerink Partners, with major backing from Eli Lilly and Andreessen Horowitz.
- A legal firm is located in New York, involving the company Starbucks.
- Wells Fargo maintains its headquarters in Waltham, MA, while conducting conferences in Boston.
- Ginkgo Bioworks is headquartered in Boston, Massachusetts.
- Neostellar Capital Corp. is headquartered in New York and maintains an office in San Francisco.